Yujiro S Hata Ideaya Biosciences, Inc. (IDYA) insider trading activity

IDYA Quotes by TradingView

Yujiro S Hata is President and CEO of IDEAYA Biosciences, Inc.. Currently has a direct ownership of 677,887 shares of IDYA, which is worth approximately $17.1 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 34,433 shares (Common Stock) at a price of $42.05 per share, resulting in proceeds of $1,447,907. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 678K
0% 3M change
0% 12M change
Total Value Held $17.1 Million

Yujiro S Hata Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
SELL
Open market or private sale
$1,447,907 $42.05 p/Share
34,433 Reduced 4.83%
677,887 Common Stock
May 16 2024
BUY
Exercise of conversion of derivative security
$148,406 $4.31 p/Share
34,433 Added 4.61%
712,320 Common Stock
May 15 2024
SELL
Open market or private sale
$3,638,511 $43.39 p/Share
83,856 Reduced 11.01%
677,887 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
$361,419 $4.31 p/Share
83,856 Added 9.92%
761,743 Common Stock
May 14 2024
SELL
Open market or private sale
$2,365,982 $41.72 p/Share
56,711 Reduced 7.72%
677,887 Common Stock
May 14 2024
BUY
Exercise of conversion of derivative security
$244,424 $4.31 p/Share
56,711 Added 7.17%
734,598 Common Stock
Feb 09 2024
SELL
Open market or private sale
$1,072,785 $45.54 p/Share
23,557 Reduced 3.36%
677,887 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
$101,530 $4.31 p/Share
23,557 Added 3.25%
701,444 Common Stock
Feb 08 2024
SELL
Open market or private sale
$3,423,047 $45.15 p/Share
75,815 Reduced 10.06%
677,887 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
$326,762 $4.31 p/Share
75,815 Added 9.14%
753,702 Common Stock
Feb 01 2024
SELL
Open market or private sale
$28,260 $45.0 p/Share
628 Reduced 0.09%
677,887 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
$2,706 $4.31 p/Share
628 Added 0.09%
678,515 Common Stock
Jan 16 2024
SELL
Open market or private sale
$2,520,225 $40.17 p/Share
62,739 Reduced 8.47%
677,887 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
$270,405 $4.31 p/Share
62,739 Added 7.81%
740,626 Common Stock
Jan 12 2024
SELL
Open market or private sale
$490,930 $40.04 p/Share
12,261 Reduced 1.78%
677,887 Common Stock
Jan 12 2024
BUY
Exercise of conversion of derivative security
$52,844 $4.31 p/Share
12,261 Added 1.75%
690,148 Common Stock
Dec 15 2023
SELL
Open market or private sale
$2,627,250 $35.03 p/Share
75,000 Reduced 9.96%
677,887 Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
$323,249 $4.31 p/Share
75,000 Added 9.06%
752,887 Common Stock
Apr 12 2023
BUY
Exercise of conversion of derivative security
$50,000 $4.31 p/Share
11,601 Added 1.68%
677,887 Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$34,480 $4.31 p/Share
8,000 Added 1.19%
666,286 Common Stock

Also insider at

XNCR
Xencor Inc Healthcare
Director
ENTA
ENANTA PHARMACEUTICALS INC Healthcare
Director
YSH

Yujiro S Hata

President and CEO
Monrovia, CA

Track Institutional and Insider Activities on IDYA

Follow IDEAYA Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDYA shares.

Notify only if

Insider Trading

Get notified when an Ideaya Biosciences, Inc. insider buys or sells IDYA shares.

Notify only if

News

Receive news related to IDEAYA Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IDYA